MBT
GILD icon

Montecito Bank & Trust’s Gilead Sciences GILD Stock Holding History

Montecito Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$868K Buy
6,872
+328
+5% +$43.2K 0.13% 143
2026
Q1 		$912K Buy
6,544
+980
+18% +$137K 0.15% 137
2025
Q4 		$683K Sell
5,564
-14
-0.3% -$1.7K 0.11% 171
2025
Q3 		$619K Buy
+5,578
New +$634K 0.1% 190
2025
Q1 		$600K Buy
5,359
+68
+1% +$7.02K 0.11% 183
2024
Q4 		$489K Hold
5,291
– – 0.08% 202
2024
Q3 		$444K Sell
5,291
-1,033
-16% -$78.8K 0.08% 219
2024
Q2 		$434K Sell
6,324
-165
-3% -$11K 0.09% 199
2024
Q1 		$475K Sell
6,489
-100
-2% -$7.69K 0.1% 181
2023
Q4 		$534K Sell
6,589
-13
-0.2% -$1.01K 0.11% 168
2023
Q3 		$495K Buy
6,602
+771
+13% +$59.3K 0.12% 165
2023
Q2 		$449K Buy
5,831
+123
+2% +$9.81K 0.1% 175
2023
Q1 		$474K Sell
5,708
-41
-0.7% -$3.4K 0.11% 168
2022
Q4 		$494K Hold
5,749
– – 0.12% 168
2022
Q3 		$355K Sell
5,749
-175
-3% -$11K 0.09% 183
2022
Q2 		$367K Sell
5,924
-30
-0.5% -$1.86K 0.09% 188
2022
Q1 		$354K Sell
5,954
-572
-9% -$36.6K 0.07% 210
2021
Q4 		$474K Sell
6,526
-176
-3% -$12.1K 0.08% 195
2021
Q3 		$468K Buy
6,702
+277
+4% +$19.5K 0.09% 188
2021
Q2 		$442K Hold
6,425
– – 0.08% 191
2021
Q1 		$415K Hold
6,425
– – 0.09% 191
2020
Q4 		$375K Sell
6,425
-1,771
-22% -$107K 0.08% 186
2020
Q3 		$518K Hold
8,196
– – 0.13% 133
2020
Q2 		$630K Buy
8,196
+1,558
+23% +$119K 0.17% 110
2020
Q1 		$497K Sell
6,638
-45
-0.7% -$3.11K 0.16% 113
2019
Q4 		$434K Sell
6,683
-254
-4% -$16.5K 0.12% 155
2019
Q3 		$440K Sell
6,937
-27
-0.4% -$1.76K 0.13% 151
2019
Q2 		$470K Sell
6,964
-1
-0% -$66 0.14% 140
2019
Q1 		$453K Hold
6,965
– – 0.14% 139
2018
Q4 		$436K Sell
6,965
-874
-11% -$61.1K 0.15% 127
2018
Q3 		$606K Sell
7,839
-2,867
-27% -$217K 0.18% 113
2018
Q2 		$759K Buy
10,706
+821
+8% +$58K 0.24% 82
2018
Q1 		$745K Sell
9,885
-172
-2% -$13.7K 0.24% 77
2017
Q4 		$720K Buy
10,057
+623
+7% +$47.3K 0.23% 69
2017
Q3 		$764K Sell
9,434
-42
-0.4% -$3.21K 0.26% 66
2017
Q2 		$671K Buy
9,476
+779
+9% +$51.8K 0.24% 74
2017
Q1 		$591K Buy
8,697
+2,582
+42% +$182K 0.22% 86
2016
Q4 		$438K Buy
6,115
+806
+15% +$59.9K 0.15% 112
2016
Q3 		$420K Sell
5,309
-6
-0.1% -$487 0.17% 117
2016
Q2 		$443K Sell
5,315
-23
-0.4% -$2.04K 0.19% 106
2016
Q1 		$490K Sell
5,338
-1,521
-22% -$137K 0.22% 83
2015
Q4 		$694K Buy
6,859
+1,679
+32% +$175K 0.33% 60
2015
Q3 		$509K Sell
5,180
-26
-0.5% -$2.89K 0.28% 67
2015
Q2 		$511K Hold
5,206
– – 0.25% 82
2015
Q1 		$511K Sell
5,206
-1,129
-18% -$115K 0.25% 82
2014
Q4 		$597K Buy
6,335
+1,651
+35% +$171K 0.31% 72
2014
Q3 		$498K Sell
4,684
-105
-2% -$10.3K 0.3% 74
2014
Q2 		$397K Buy
4,789
+1,391
+41% +$108K 0.24% 86
2014
Q1 		$240K Buy
3,398
+56
+2% +$4.39K 0.15% 119
2013
Q4 		$251K Buy
+3,342
New +$233K 0.16% 114

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Montecito Bank & Trust's GILD Position: Q2 2026 in Review

Montecito Bank & Trust increased its Gilead Sciences (GILD) stake by 5% in Q2 2026, buying an estimated $43.2K and bringing the position to 6,872 shares worth $868K. The position accounts for 0.13% of the portfolio, ranked #143.

Montecito Bank & Trust first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $912K in Q1 2026. 514 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Montecito Bank & Trust held 6,872 shares of Gilead Sciences worth $868K as of Q2 2026.
  • Montecito Bank & Trust bought 328 Gilead Sciences shares in Q2 2026, an estimated $43.2K.
  • Gilead Sciences made up 0.13% of Montecito Bank & Trust's portfolio in Q2 2026, its #143 holding.
  • Montecito Bank & Trust first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Montecito Bank & Trust's Gilead Sciences position peaked at $912K in Q1 2026.
  • 514 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Montecito Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.